Physician profile
Leon Yoder
NPI 1285621482
$1,115.11
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $277 · 2022: $144.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.38 | 2019-2020 | |
| Boston Scientific Corporation | $187.03 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.78 | 2019 | |
| Genentech USA, INC. | $145.47 | 2019 | |
| Lilly USA, LLC | $75.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $74.08 | 2019-2020 | |
| Amgen INC. | $36.72 | 2019 | |
| Genzyme Corporation | $35.75 | 2019 | |
| Array Biopharma INC | $32.98 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $28.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.74 | 2020 | |
| Celgene Corporation | $16.78 | 2019 | |
| Alfasigma USA, INC. | $14.02 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.